Kroger operates in several store formats, offering its customers the option to shop in its stores in-person or online for delivery or pickup.
Founded in 1883 as a small grocery store, Kroger is the largest supermarket operator in the US. Globally, it is surpassed only by Walmart in grocery sales.
United Therapeutics (UTHR) rose 4.7% due to positive 3Q15 results. It announced revenue of $386 million for 3Q15—compared to revenue of $330 million in 3Q14.
Vertex Pharmaceuticals (VRTX) rose 5% due to better-than-expected revenue for 3Q15. Vertex announced $310 million in revenue in 3Q15.
Amgen (AMGN) announced its 3Q15 earnings. It reported revenue of $5,723 million for 3Q15—a 14% rise from the earnings in 3Q14.
In this part, we’ll look at the unit contribution of AT&T’s wireless postpaid subscribers.
XBI fell by 2.5%. It was led by the fall in small-caps as of October 29. In XBI’s portfolio, 21 stocks ended in green and 80 stocks gave a negative return.
Now let’s look at the growth of AT&T’s wireless customers during the quarter. Overall, the telecom company’s wireless postpaid subscribers grew ~2.1%.
In the next two parts, we’ll focus on AT&T’s customer metrics in its overall domestic wireless operations for the quarter.
The rising penetration of AT&T’s Next plan is positively affecting its equipment revenue in its wireless segments.
AT&T’s wireless service revenue continued its YoY declining trend in 3Q15. Meanwhile, wireless equipment revenue continued to increase in 3Q15.
In this series, we’ll look at the performance of AT&T’s (T) overall domestic wireless component in 3Q15. Note that AT&T has divided its operations into four new divisions.
On October 28, the iShares US Medical Devices ETF (IHI) gained 1.75%, following the market trend. The S&P 500 was up by 1.2% and the SPDR S&P 500 ETF (SPY) was up by 1.15%.
69.6% of firms rated Gilead Sciences (GILD) as a “buy,” 26.1% recommended a “hold,” and 4.3% firms rated the company as “sell.”
After the release of its 3Q15 earnings results on October 27, 2015, Gilead Sciences (GILD) traded at a price-to-earnings (or PE) multiple of 9.1x.
In 3Q15, Gilead Sciences (GILD) recorded total operating expenses of about $2.7 billion, an increase of 5.8% over 3Q14.
Farmer Brothers (FARM) recorded net sales for 4Q15 that increased by $2.4 million, or 1.8%, to $132.6 million. The company recorded $130.2 million in 4Q14.
Farmer Brothers’ (FARM) gross profit in 4Q15 increased by $3.7 million, or 8.2%, to $49.2 million. It recorded a 4Q14 gross margin of $45.5 million.
In 3Q15, Gilead Sciences returned capital to shareholders through share repurchase programs, cash dividend programs, and warrants repurchases.
Farmer Brothers (FARM) reported EPS (earnings per share) of $0.23 in 4Q15, beating consensus estimates by ~44%.